Table 2.
Sumatriptan | Mexiletine | 20b | (R)-31b | |||||
---|---|---|---|---|---|---|---|---|
A: 0.1 Hz | ||||||||
Mexiletine | yes | |||||||
yes | ||||||||
20b | yes | yes | ||||||
yes | yes | |||||||
(R)-31b | yes | yes | ns | |||||
yes | yes | ns | ||||||
(S)-22b | yes | yes | yes | yes | ns | yes | ns | |
yes | yes | yes | yes | |||||
B: 10 Hz | ||||||||
Mexiletine | yes | |||||||
yes | ||||||||
20b | yes | yes | yes | |||||
yes | yes | |||||||
(R)-31b | yes | yes | yes | ns | ||||
yes | yes | yes | ||||||
(S)-22b | yes | yes | yes | yes | yes | yes | yes | |
yes | yes | yes | ns |
The percentages of inhibition of sodium channels by the various drugs at each concentration, as reported in concentration–response relationships (Figure 3), were compared using ANOVA followed by ad hoc Bonferroni’s t-test. The significance is reported as “yes” (at least p < 0.05) or “ns” (not significant) in cyan cells (for comparison at 30 μM), yellow cells (100 μM), orange cells (300 μM), and pink cells (1000 μM). Note that sumatriptan was not tested at 30 μM (gray cells).